R Kent Jr McGaughy
CIK 1402856 · last filed 2025-05-29
R Kent Jr McGaughy is a corporate insider who has filed 46 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for TIL, was dated May 29, 2025. Across all open-market trades the lifetime net is +$65.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $65.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$65.09M
5
46
$65.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TIL | Director | 8,218,467 | $7.92 | $65.09M | $9.00M | 7 | 2025-05-29 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 0 | $172.36 | $0 | $46.76M | 29 | 2023-09-26 |
| Apollo Endosurgery, Inc. (APEN) Delisted | Director | 0 | $10.00 | $0 | $10.02M | 8 | 2023-04-04 |
| Apollo Endosurgery, Inc. (LPTN) Delisted | Director | 36,608 | — | — | $0 | 1 | 2016-12-30 |
| GTOP | Director | — | $48.03 | — | $0 | 1 | 2007-06-13 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-29 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-01-10 | TIL | Grant (A) | — | $0 | EDGAR |
| 2023-09-26 | REATA PHARMACEUTICALS INC (RETA) Delisted | Disp (D) | −2,926,776 | $0 | EDGAR |
| 2023-06-09 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | Apollo Endosurgery, Inc. (APEN) Delisted | Disp (D) | −6,183,603 | $0 | EDGAR |
| 2023-03-07 | REATA PHARMACEUTICALS INC (RETA) Delisted | Gift (G) | −33,217 | $0 | EDGAR |
| 2022-12-30 | Apollo Endosurgery, Inc. (APEN) Delisted | Conv (C) | +2,198,655 | $7.15M | EDGAR |
| 2022-06-16 | Apollo Endosurgery, Inc. (APEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |